Clinical trial
Tecfidera Slow-Titration Study
NCT02428231
Study timeline
Study start (unknown)2015-04-01Date precision: month
Registry last updated2017-05-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Interventions
dimethyl fumarateDRUG · verified · RxNorm: dimethyl fumarate
Sponsors & collaborators
Biogenlead sponsor
Mapped research locations
DallasTexas, United States1MiamiFlorida, United States1CincinnatiOhio, United States1PhoenixArizona, United States1CharlotteNorth Carolina, United States1PragueCzechia1Long BeachCalifornia, United States1LeuvenBelgium1Overland ParkKansas, United States1AshevilleNorth Carolina, United States1WilmingtonNorth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02428231 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.